Novel GLP-1 Fusion Chimera as Potent Long Acting GLP-1 Receptor Agonist

Qinghua Wang, Kui Chen, Rui Liu et al. · 2010

Read Novel GLP-1 Fusion Chimera as Potent Long Acting GLP-1 Receptor Agonist by Qinghua Wang, Kui Chen, Rui Liu et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0012734.txt.

Description

Wang, Chen, Liu and co-authors engineered a longer-lasting version of a diabetes hormone. GLP-1 lowers blood sugar in several helpful ways, but the natural hormone breaks down in under two minutes. Their 2010 paper fused GLP-1 to other protein parts, building a chimera meant to survive in the body.

The fused protein kept strong action on the GLP-1 receptor while lasting far longer. Long action means fewer injections and steadier sugar control for patients. Their design adds one more entry to the race for weekly diabetes drugs. Sugar control was checked in diabetic animal models too.

Catalog record

CREATORQinghua Wang, Kui Chen, Rui Liu et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE42 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012734

Browse the full library · About the Tower of Babel